Company profile for aVaxziPen

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

aVaxziPenTM is developing next-generation vaccination products targeting infectious diseases and emergent threat pathogens enabled by its proprietary aVaxziPen technologies. aVaxziPen creates and delivers vaccines in needle-free, thermally stable, solid dose format that is applicable across all types of vaccines. aVaxziPen was formerly known as Enesi Pharma. It was founded in 2017 and is based in Oxfordshire, United Kingdom.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
United Kingdom
Address
Address
120 A&B Olympic Avenue Milton Park Abingdon Oxfordshire, OX14 4SA
Telephone
Telephone
+44 (0) 1235 577 120
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2023/06/06/2682508/0/en/Needle-free-vaccine-delivery-platform-aims-to-end-frozen-storage-needs-and-improve-access.html

GLOBENEWSWIRE
06 Jun 2023

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty